Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03513731 · ClinicalTrials.gov registry record · NA
Safety of Adipose-derived Regenerative Cells Injection for Treatment of Osteoarthritis of the Facet Joint
A NA study of Osteoarthritis of Facet Joint of Lumbar Spine, sponsored by InGeneron.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT03513731: Recruiting NA study of Osteoarthritis of Facet Joint of Lumbar Spine, sponsored by InGeneron.
NCT03513731 is a NA study of Osteoarthritis of Facet Joint of Lumbar Spine that is actively recruiting participants, run by InGeneron. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03513731, a NA study of Osteoarthritis of Facet Joint of Lumbar Spine, is actively recruiting participants, sponsored by InGeneron.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective, randomized, active controlled, single site safety and efficacy study in subjects suffering from chronic lumber back pain due to facet joint osteoarthritis comparing a single ADRC injection generated with the Transpose® RT system into the facet joint.
Primary Outcome
Subjects will be monitored for adverse events
Conditions Studied
Interventions
- DRUG Corticosteroid injection
- DEVICE Adipose-derived stem cell injection
Study Locations (2)
Florida
- Sports and Orthopedic Center - Deerfield Beach
South Dakota
- Sanford Physical Medicine & Rehabilitation Clinic and Sanford Spine Center - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-12-07 |
| Est. Completion | 2026-04 |
| Phase | NA |
What NCT03513731 shows while recruiting
NCT03513731 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Osteoarthritis of Facet Joint of Lumbar Spine appearing as the primary indexed condition, and to 2 interventions - of which Corticosteroid injection is the first listed.
NCT03513731 reports a single indexed study location in Florida, South Dakota.
Frequently Asked Questions
What is clinical trial NCT03513731 about?
NCT03513731 is a clinical study titled "Safety of Adipose-derived Regenerative Cells Injection for Treatment of Osteoarthritis of the Facet Joint". This is a prospective, randomized, active controlled, single site safety and efficacy study in subjects suffering from chronic lumber back pain due to facet joint osteoarthritis comparing a single ADRC injection generated with the Transpose® RT system into the facet joint.
What is the current status of trial NCT03513731?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2018-12-07. Estimated completion is 2026-04.
What conditions does trial NCT03513731 study?
This clinical trial studies the following conditions: Osteoarthritis of Facet Joint of Lumbar Spine.
What interventions are being tested in trial NCT03513731?
The interventions under investigation include: Corticosteroid injection (DRUG), Adipose-derived stem cell injection (DEVICE).
Who is sponsoring clinical trial NCT03513731?
This trial is sponsored by InGeneron, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03513731 being conducted?
This trial has 2 study locations across Florida, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03513731's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI